Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms
Rebecca A. Harrison(BC Cancer Agency), Shelli R. Kesler(Livestrong Foundation), Melissa Petersen(University of North Texas), Ashley M. Henneghan(The University of Texas at Austin), Brennan Parmelee Streck(National Cancer Institute), Jennie L. Rexer(The University of Texas MD Anderson Cancer Center), Noha Sharafeldin(University of Alabama at Birmingham)
Cited by 33
Related Papers
Prevalence of cancer survivors in the United States
|JNCI Journal of the National Cancer Institute|2024|240
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
|JNCI Journal of the National Cancer Institute|2021|115
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
|Frontiers in Psychology|2022|87
Disrupted brain network functional dynamics and hyper‐correlation of structural and functional connectome topology in patients with breast cancer prior to treatment
|Brain and Behavior|2017|78
Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review
|Supportive Care in Cancer|2015|62